BTN3A1 and neoplasm: In addition, targeting of BTN3A1 has been shown to transform BTN3A1 from an immunosuppressive to an immunostimulatory molecule, by inducing γδ T-cell-mediated anti-tumor cytotoxicity, resulting in the killing of specific tumor cells by γδ T cells.